Biomarkers are emerging as a potential tool for screening or diagnosing sarcopenia. We
aimed to summarize the current evidence on the diagnostic test accuracy of biomarkers for …

Sarcopenia is a gradual loss of skeletal muscle mass and function with aging. Given that
sarcopenia has been recognized as a disease entity, effective molecular biomarkers for …

Loss of muscle mass and strength with aging, termed sarcopenia is accelerated in several
comorbidities including chronic heart failure (CHF) and chronic obstructive pulmonary …

Objective This review aimed to summarise the diagnostic accuracy of screening tools for
sarcopenia. Methods We conducted a systematic review along with a critical appraisal of …

Background Sarcopenia leads to serious adverse health consequences. There is a dearth of
screening tools for this condition, and performances of these instruments have rarely been …

Objective Choosing the optimal sarcopenia screening tool for a specific clinical scenario is
challenging. We aimed to summarize all validated sarcopenia screening tools with …

Objective To examine the screening ability of SARC-F for older adults using a meta-analysis.
Design Meta-analysis. Setting and Participants The literature review was conducted using …

The term sarcopenia describes the age-related loss of skeletal muscle mass and function.
While this process, in principal, occurs in every adult person and already starts around the …

Background Several creatinine-and cystatin-C–based indices have been proposed as
sarcopenia predictors. This study aimed to compare serum creatinine-and cystatin-C–based …

Background Sarcopenia is a potentially reversible condition, which requires proper
screening and diagnosis. Aims To validate a Polish version of sarcopenia screening …